| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/30/2006 | US20060069075 Methods for treating dry eye |
| 03/30/2006 | US20060067982 Encasing a core made of a siloxane-based elastomer containing dexamethasone, betamethasone, beclomethasone, and/or budesonide with a membrane made of the same or a different elastomer; and shaping the device into a shape suitable for implantation into the ear or nose |
| 03/30/2006 | US20060067932 Antagonists specific for denatured collagen and methods of using same |
| 03/30/2006 | US20060067928 Contacting a linear polysaccharide with a disaccharide repeat unit of a uronic acid [ alpha -L-iduronic acid (I) or beta -D-glucuronic acid] linked 1, 4 to alpha -D-hexosamine with a modified heparinase III in vitro |
| 03/30/2006 | CA2575265A1 Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat ophthalmic disorders |
| 03/29/2006 | EP1640449A1 Cell differentiation inhibiting agent, cell culture method using the same, culture medium and cultured cell line |
| 03/29/2006 | EP1640369A1 Thiazolimine compound and oxazolimine compound |
| 03/29/2006 | EP1638936A1 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 03/29/2006 | EP1638591A1 Class iii slrp agonists for the reduction of blood vessel formation |
| 03/29/2006 | EP1638550A1 Coumarin derivatives for the treatment of ophthalmic disorders |
| 03/29/2006 | EP1638524A1 Composition and method for the treatment of water related ear disorders |
| 03/29/2006 | EP1385496A4 Use of compositions for treating rosacea |
| 03/29/2006 | EP1330453B1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 03/29/2006 | CN1753913A Medicinal composition for ophthal use containing acetylated hyaluronic acid |
| 03/29/2006 | CN1753677A Ocular hypotensive agent |
| 03/29/2006 | CN1751736A Traditional Chinese medicine for treating early senile cataract and its prepn. method |
| 03/29/2006 | CN1751729A Traditional Chinese medicine for treating intermediate senile cataract and its prepn. method |
| 03/29/2006 | CN1751703A Injection for treating ophthalmopathy |
| 03/29/2006 | CN1751692A Medicine Rb2 used for thrombolysis, anti reperfusion injury, improving microcirculation and repairing injured tissue and its prepn. method |
| 03/29/2006 | CN1247593C Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 03/29/2006 | CN1247586C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 03/29/2006 | CN1247585C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives |
| 03/29/2006 | CN1247584C I-[alkyl] 1-[(heteroaryl) alkyl] and 1 [(aryl) alkyl] 7-pyridinyl-imidazo [1,2-a] pyrimidin-5(1h)-one derivatives |
| 03/29/2006 | CN1247577C Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 03/29/2006 | CN1247576C Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/29/2006 | CN1247575C Sulfamino ether substituted imidazoquinolines |
| 03/29/2006 | CN1247567C 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors |
| 03/29/2006 | CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 03/29/2006 | CN1247542C Substituted pyrrole Mannich bases to treating paint and allergic reactions |
| 03/29/2006 | CN1247523C Substituted 1 and 2 naphthol mannich bases |
| 03/29/2006 | CN1247261C Combined bacterin for treating allergic disease and preparation method |
| 03/29/2006 | CN1247248C Nutrient food with eyes enriching and vision promoting function |
| 03/29/2006 | CN1247240C Herbal medicine compositions for treatment allergic rhinitis and use thereof |
| 03/29/2006 | CN1247225C Fumigant with eyes enriching, vision promoting, asthenopia relieving function |
| 03/29/2006 | CN1247193C Eye drops |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019016 Therapy of sensorineural hearing loss in a mammal by administering NR2B subunit selective N-methyl-D-aspartate (NMDA) NR2B subtype receptor antagonist |
| 03/28/2006 | US7019013 Sulfamidothienopyrimidines |
| 03/28/2006 | US7019007 CCR-3 receptor antagonists (I) |
| 03/28/2006 | US7018998 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease |
| 03/28/2006 | US7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors |
| 03/28/2006 | US7017573 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 03/28/2006 | CA2395186C Procollagen c-proteinase inhibitors |
| 03/28/2006 | CA2343459C Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/23/2006 | WO2006031786A2 Protein a compositions and methods of use |
| 03/23/2006 | WO2006031467A2 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith |
| 03/23/2006 | WO2006030907A1 Retina protective agent |
| 03/23/2006 | WO2006030851A1 Pirenoxine suspension type eye lotion |
| 03/23/2006 | WO2006030805A1 Triazole derivative or salt thereof |
| 03/23/2006 | WO2006030753A1 Therapeutic agent for keratoconjunctiva disorder |
| 03/23/2006 | WO2006030285A1 New 1,2,4-triazole-3-carboxamide derivatives |
| 03/23/2006 | WO2006029685A1 Barn dust extract providing protection from allergies |
| 03/23/2006 | WO2006029487A2 Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063809 Tri-substituted heteroaryls and methods of making and using the same |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063729 Ocular gene therapy |
| 03/23/2006 | US20060062807 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 03/23/2006 | US20060062782 Anti-IgE vaccines |
| 03/23/2006 | US20060062765 Lentiviral vector-mediated gene transfer and uses thereof |
| 03/23/2006 | DE102004045720A1 Stabile Dosierungsform von Phenylalanin-Derivaten Stable dosage form of phenylalanine derivatives |
| 03/23/2006 | CA2580517A1 Protein a compositions and methods of use |
| 03/23/2006 | CA2580409A1 Triazole derivative or salt thereof |
| 03/23/2006 | CA2579490A1 Therapeutic agent for keratoconjunctiva disorder |
| 03/22/2006 | EP1637533A1 Substituted thiazolopyrimidines as analgetics |
| 03/22/2006 | EP1637532A1 Fused pyrimidine derivative |
| 03/22/2006 | EP1637527A1 Cannabinoid receptor modulator |
| 03/22/2006 | EP1637521A1 Novel tricyclic heterocycle compound |
| 03/22/2006 | EP1637147A1 Stable dust extract for allergy protection |
| 03/22/2006 | EP1635909A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 03/22/2006 | EP1635855A2 Selective r-cadherin antagonists and methods |
| 03/22/2006 | EP1635842A1 Treatment of amd with combination of ingredients |
| 03/22/2006 | EP1472221B1 Substituted indoles, method for production and use thereof for the inhibition of pain |
| 03/22/2006 | EP1448219B1 Antiglaucomatous agent and use thereof |
| 03/22/2006 | EP1412357B1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/22/2006 | EP1381620B1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 03/22/2006 | EP1272488B1 Tri-aryl-substituted-ethane pde4 inhibitors |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | EP0914456B1 Gene expression in monocytes and macrophages |
| 03/22/2006 | CN1750838A Medical drug containing fine particle of noble metal |
| 03/22/2006 | CN1750837A Superoxide anion decomposing agent |
| 03/22/2006 | CN1748785A Water solution preparation of reducing type glutathione, its preparing method and use |
| 03/22/2006 | CN1748703A Gatifloxacin eye drop and its preparing method |
| 03/22/2006 | CN1246311C Pyrrolidines which inhibit CAMP-specific PDE |
| 03/22/2006 | CN1246025C Medicine for treating diabetes and eye disease |
| 03/22/2006 | CN1245991C Shark meat extract |
| 03/22/2006 | CN1245990C Powdered eye disease treating medicine |
| 03/22/2006 | CN1245981C Liquid preparation made from pazufloxacin leucinocaine fed through eye and producing method |
| 03/22/2006 | CN1245978C Preventive or therapeutic drugs for various eosinophilia realated diseases containing chymase inhibitors as active ingredient |
| 03/22/2006 | CN1245973C Use of biochemical material for preparing medicine for preventing and treating disease caused by smooth muscle cell contraction in human organ |
| 03/22/2006 | CN1245966C Use of beta-adrenoceptor antagonists for manufacture of medicament for treatment of disorders of outer retina |
| 03/21/2006 | US7015325 Alkyne oxy carbamate derivatives used to treat respiratory system disorders |
| 03/21/2006 | US7015243 Cyclohexyl prostaglandin analogs as EP4-receptor agonists |
| 03/21/2006 | US7015240 Treatment of macular edema |
| 03/21/2006 | US7015234 Hydroxamic acid derivatives |
| 03/21/2006 | US7015210 Methods of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| 03/21/2006 | US7015192 synthetic hexapeptides or oligopeptides used as neurosecretion antagonists; bloking release of catecholamines; wrinkling and aging resistance |
| 03/21/2006 | US7014867 Tablet comprising cetirizine and pseudoephedrine |
| 03/21/2006 | US7014838 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 03/21/2006 | CA2315220C Integrin receptor antagonists |